Aegis Capital Starts Rosetta Genomics (ROSG) at Buy, PT of $3.50

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. MRVL
2. ZS
3. PENG
4. NVDA
5. STZ
6. MSFT
7. SPY
8. SKYD
9. IBM
10. CRWV

Go back to Aegis Capital Starts Rosetta Genomics (ROSG) at Buy, PT of $3.50

Rosetta Genomics (ROSG) Receives U.S. Patent Allowance Related to microRNAs as Liver Cancer Treatment

January 11, 2016 9:12 AM EST

Rosetta Genomics Ltd. (NASDAQ: ROSG) announces that the U.S. Patent and Trademark Office (USPTO) has granted a patent allowance for patent application No. 08844596.0, relating to Targeting microRNAs for the Treatment of Liver Cancer. This patent is co-owned by Regulus Therapeutics, Inc. (Nasdaq: RGLS). The patent claims chemically-modified,... More